Two Warner Bros. Discovery directors resign after antitrust probe

Two Warner Bros. Discovery directors resign after antitrust probe


The exterior of the Warner Bros. Discovery Atlanta campus is pictured after the Writers Guild of America began its strike against the Alliance of Motion Pictures and Television Producers, in Atlanta, Georgia, on May 2, 2023.

Alyssa Pointer | Reuters

Two Warner Bros. Discovery directors, Steven Miron and Steven Newhouse, are resigning following a U.S. Department of Justice investigation into a potential antitrust violation, according to a company release Monday.

The company said Miron and Newhouse, who were both appointed as directors in April 2022 as part of the WarnerMedia and Discovery merger, were being investigated as to whether their participation on the board was in violation of Section 8 of the Clayton Antitrust Act, which largely prohibits directors from serving simultaneously on the boards of competitors.

Miron is the CEO of privately held media company Advance/Newhouse Partnership and a senior executive officer at Advance, which invests in media and technology companies, according to the release. Newhouse is co-president of Advance.

Both of their terms on the Warner Bros. board were set to expire in 2025.

Rather than contesting the DOJ matter, the company said both Miron and Newhouse voluntarily elected to resign from their positions, effective immediately. Neither director admitted any violation.

“We are proud to have played a role in the building of this great company and remain a large stockholder. We are disappointed to leave the Board, but wish to do the right thing for WBD,” Newhouse said in a statement.



Source

Disney names parks boss Josh D’Amaro as its next CEO to succeed Bob Iger, effective March 18
Business

Disney names parks boss Josh D’Amaro as its next CEO to succeed Bob Iger, effective March 18

Disney has named Josh D’Amaro, chairman of Disney Experiences, as its next CEO, succeeding Bob Iger and clinching a closely watched succession race at the Mouse House. Investors, industry insiders and onlookers have long awaited the announcement of who will take over as the next leader of one of the most storied U.S. companies. The […]

Read More
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
Business

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. Patients with obesity or who are overweight lost up to 12.3% of their weight compared with placebo at week 28 in […]

Read More
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
Business

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Albert Bourla, CEO of Pfizer, speaking on Squawk on the Street at the World Economic Forum in Davos, Switzerland on Jan. 20, 2026. Oscar Molina | CNBC Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its modest 2026 guidance that rattled investors in December. […]

Read More